Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can Novavax Stock Double in 2022?

TheMotleyFool

0 0

Once upon a time, Novavax (NASDAQ: NVAX) ranked as the hottest COVID-19 vaccine stock around. These days, Novavax is anything but hot. Its shares are down more than 40% so far this year and more than 70% below their 52-week high.

Some might have written Novavax off as a lost cause. But can this beaten-down stock double in 2022?

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Share